Bio Soft Research
Indore, India· Est.
AI‑driven CRO delivering decentralized trial and data‑science services to accelerate drug development.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
AI Company Overview
AI‑driven CRO delivering decentralized trial and data‑science services to accelerate drug development.
Technology Platform
Bio Soft Research’s AI‑enhanced statistical programming and data‑science platform integrates machine‑learning‑driven data cleaning, real‑time analytics, and decentralized trial technologies to support risk‑based quality management and patient‑centric study execution.
Opportunities
Expanding demand for decentralized clinical trials and AI‑driven data analytics offers substantial growth potential across global pharma and biotech sponsors.
Risk Factors
Reliance on emerging technologies may face regulatory scrutiny, and competition from larger CROs with deeper resources could limit market share.
Competitive Landscape
Competes with traditional CROs and emerging digital‑trial providers; differentiation stems from its early AI integration and dedicated DCT focus.